Figure 4.
Vaccine effectiveness for different categories: 3–11 and 12–17 age subgroups, Females (F), Males (M), subjects with comorbidities (C) and without them (NC), and SARS-CoV-2 infection naive-subjects (Naive). Error bars indicate the %[CI95%].
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.